Juan Carlos Rodríguez-Duque

National digestive disease specialists survey on cardiovascular risk management in non‐alcoholic fatty liver disease in spanish hospitals

J. Crespo, A. Cuadrado, P. Iruzubieta, 2021, Liver international : official journal of the International Association for the Study of the Liver.

Efficacy and safety of endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy in obese subjects with Non-Alcoholic SteatoHepatitis (NASH): study protocol for a randomized controlled trial (TESLA-NASH study)

M. T. Arias-Loste, L. LAVIN-ALCONERO, M. Cagigal, 2021, Trials.

Prevalence of antinuclear antibodies in inflammatory bowel disease and seroconversion after biological therapy

M. López-Hoyos, M. T. Arias-Loste, Juan Carlos Rodríguez-Duque, 2022, Therapeutic advances in gastroenterology.

Prevalence of antinuclear antibodies in inflammatory bowel disease and seroconversion after biological therapy

M. López-Hoyos, M. T. Arias-Loste, Juan Carlos Rodríguez-Duque, 2022, Therapeutic advances in gastroenterology.

Faecal Microbiota Transplantation, Paving the Way to Treat Non-Alcoholic Fatty Liver Disease

P. Iruzubieta, A. Santos-Laso, M. T. Arias-Loste, 2023, International journal of molecular sciences.

Increased risk of MAFLD and liver fibrosis in inflammatory bowel disease independent of classic metabolic risk factors.

J. Vaqué, J. Calleja, J. Crespo, 2022, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

NAFLD and type 2 diabetes: A practical guide for the joint management

P. Iruzubieta, J. Crespo, Juan Carlos Rodríguez-Duque, 2022, Gastroenterologia y hepatologia.